Senior Software Engineer II

Chicago, Illinois, United States

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Precision Medicine, Biotechnology, SaaSIndustries

Requirements

Candidates are required to have 5+ years of advanced TypeScript/JavaScript development experience with a deep understanding of language features and optimization techniques, extensive experience architecting and leading development with Node.js and NestJS frameworks, expert-level React development, advanced PostgreSQL skills including query optimization and performance tuning, proven expertise implementing sophisticated Redis caching solutions, demonstrated success designing and implementing distributed microservice architectures, significant experience orchestrating infrastructure on GCP, mastery of enterprise-level design patterns, and experience mentoring engineering teams.

Responsibilities

The Senior Software Engineer II will be responsible for building solutions that make a meaningful impact in cancer research and treatment, designing and implementing complex component systems, optimizing PostgreSQL databases, implementing sophisticated Redis caching solutions, designing and implementing distributed microservice architectures, orchestrating infrastructure on GCP, and presenting technical solutions to diverse stakeholders.

Skills

TypeScript

JavaScript

Node.js

NestJS

React

PostgreSQL

Redis

Microservices

GCP

CI/CD

Design Patterns

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters

2015Year Founded

$894.9MTotal Funding

IPOCompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.

Ambry Genetics acquisition could pose financial risks if synergies aren't realized.

Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.

Their platform aids in personalized treatment decisions for cancer patients.

Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.

Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.

Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI

Try Jobo Free